Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Clinical Gastroenterology|October 15, 2021
Demographics of Gastroparesis Hospitalizations Through the Age Spectrum Using National Inpatient Databases: Children Compared With AdultsDariush Shahsavari, Rachel Thomas, Adam C Ehrlich, et al.
The American Journal of Gastroenterology|March 12, 2025
Long-Term Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis: An Integrated 2-Year Safety AnalysisScott D Lee, Adam C Ehrlich, Paola Pellanda, et al.
Digestive Diseases and Sciences|February 23, 2018
Gastric Per Oral Endoscopic Myotomy (G-POEM) for the Treatment of Refractory Gastroparesis: Early ExperienceZubair Malik, Rahul Kataria, Rani Modayil, et al.
Journal of Clinical Gastroenterology|December 19, 2019
Factors Associated With Hospital Admissions and Readmissions in Patients With Gastroparesis Using the Nationwide Readmission DatabaseDariush Shahsavari, Huaqing Zhao, Adam C Ehrlich, et al.
Inflammatory Bowel Diseases|April 27, 2024
Global Epidemiology and Geographic Variations of Pediatric-Onset Inflammatory Bowel Disease: A Comprehensive Analysis of the Global Burden of Disease Study 1990 to 2019Yichen Wang, Chun-Wei Pan, Yuting Huang, et al.
The American Journal of Managed Care|August 19, 2025
US health care disparities in immunology biologics access: a systematic reviewGrace C Wright, Ginette A Okoye, Adam C Ehrlich, et al.
The American Journal of Managed Care|September 18, 2025
Disparities in physician access for rheumatology, dermatology, and gastroenterology: a systematic reviewGrace C Wright, Ginette A Okoye, Adam C Ehrlich, et al.
Digestive Diseases and Sciences|May 5, 2021
Virtual Gastroenterology Fellowship Recruitment During COVID-19 and Its Implications for the FutureNour Hamade, Indira Bhavsar-Burke, Claire Jansson-Knodell, et al.
Crohn'S & Colitis 360|April 22, 2025
Efficacy and Safety of Mirikizumab in the Treatment of Moderately to Severely Active Ulcerative Colitis Regardless of Baseline Modified Mayo Score: Results From the Phase 3 LUCENT TrialsBincy Abraham, Jianmin Wu, Séverine Vermeire, et al.
Gastroenterology|October 4, 2020
Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National RegistryColleen R Kelly, Eugene F Yen, Ari M Grinspan, et al.
Pageof 2